Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Ltd announced board approval for significant corporate actions including an increase in authorized share capital from INR 115 Cr to INR 150 Cr. Additionally, the company plans a preferential issue to Rasmalai Limited, a Cyprus-based entity, for up to INR 3,150.00 Cr. This will involve issuing equity shares and warrants, representing a minority investment of 24.87% on a fully diluted basis. The transaction is subject to shareholder and regulatory approvals.

Yatharth Hospital & Trauma Care Services Limited's Board of Directors has approved a preferential issue of equity shares and warrants to Rasmalai Limited, a Cyprus-based entity. The total consideration for this private placement is up to INR 3,150.00 crore. This includes the issuance of up to 13,026,516 equity shares at INR 985.17 per share and up to 18,947,664 warrants at the same price, with 25% payable upfront. The company also approved an increase in its authorized share capital from INR 115 crore to INR 150 crore. This transaction, subject to shareholder and regulatory approvals, represents a minority investment of 24.87% on a fully diluted basis.

Yatharth Hospital & Trauma Care Services Ltd. has announced a significant primary investment of ₹3,150 crore from global private equity firm Advent International. Upon completion, Advent will acquire a 24.9% minority stake in the company. This investment is one of the largest primary infusions by a private equity firm in India's hospital sector and is expected to accelerate Yatharth Hospitals' growth. The Tyagi family will remain the largest shareholder, guiding the company's long-term vision. Yatharth Hospitals operates nine multi-speciality hospitals with approximately 2,800 beds.

Yatharth Hospital & Trauma Care Services Limited's Board of Directors has approved an increase in authorized share capital from INR 115 Crores to INR 150 Crores. Additionally, the Board has approved a preferential issue of equity shares and warrants to Rasmalai Limited for up to INR 3,150 Crores. This includes issuing approximately 1.30 crore equity shares at INR 985.17 each and 1.89 crore warrants at the same price. The transaction, subject to shareholder and regulatory approvals, represents a minority investment of 24.87% on a fully diluted basis.

Yatharth Hospital & Trauma Care Services Ltd has announced a Board of Directors meeting scheduled for September 17, 2026. The primary agenda is to consider and approve growth plans and the associated fundraising strategies. These strategies may include debt, rights issue, preferential allotment, qualified institutions placement, or a combination thereof, utilizing instruments like equity shares, warrants, or convertible securities. The company also informed that the trading window for designated persons will be closed until 48 hours after the board meeting conclusion.

Yatharth Hospital and its subsidiaries, AKS Medical and Ramraja Multispeciality Hospital, have received final assessment orders from the Deputy Commissioner of Income Tax, resulting in aggregate demands of ₹29.66 Crores plus ₹11.42 Crores interest for Yatharth Hospital, ₹8.50 Crores plus ₹2.48 Crores interest for AKS, and ₹5.64 Crores plus ₹2.04 Crores interest for Ramraja. The company, based on external tax consultant advice, is filing appeals before the CIT (Appeals) and is confident of substantial relief, thus not requiring any provision in the financial statements currently.

Yatharth Hospital & Trauma Care Services Ltd has submitted its Business Responsibility and Sustainability Reporting (BRSR) for the financial year 2025-26. The report, filed as per SEBI regulations, details the company's corporate identity, business activities, operations, employee data, and market presence. The company operates solely in hospital activities, with healthcare services accounting for 100% of its turnover. The BRSR will be available on the company's website. The reporting boundary is consolidated.

Yatharth Hospital & Trauma Care Services Ltd has submitted its Annual Report for FY 2025-26 and the Notice for its 19th Annual General Meeting (AGM). The AGM is scheduled for September 25, 2026, to be held via Video Conferencing. Key agenda items include the adoption of audited standalone and consolidated financial statements for FY 2025-26, re-appointment of a director, and ratification of the Cost Auditor's remuneration for FY 2026-27. E-voting facilities are available to members from September 22 to September 24, 2026.

Yatharth Hospital & Trauma Care Services Ltd has announced its 19th Annual General Meeting (AGM) scheduled for Friday, September 25, 2026, at 12:00 Noon IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company will present the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Key agenda items include the adoption of financial statements, re-appointment of a director retiring by rotation, and ratification of the Cost Auditor's remuneration for FY 2026-27. E-voting facilities are available for members from September 22 to September 24, 2026, with a cut-off date of September 18, 2026, for determining voting eligibility. The Annual Report and AGM Notice are available on the company's website.

Yatharth Hospital & Trauma Care Services Ltd has issued a clarification regarding a news item suggesting Aster and Advent are eyeing a controlling stake. The company stated that there is no information requiring disclosure under SEBI's Listing Regulations. Yatharth Hospital confirmed it explores strategic opportunities in the best interest of stakeholders and will promptly disclose any material information as required. The company also noted that its financial results for the quarter ended June 30, 2026, were declared on August 10, 2026, and are publicly available. No regulatory or legal proceedings have been initiated or concluded.